T1	Participants 102 125	herpes simplex labialis
T2	Participants 383 412	herpes simplex labialis (HSL)
T3	Participants 431 603	An assessment of CSP efficacy and safety was conducted in an international, multicentre, assessor-blinded study, which enrolled 728 subjects with a history of recurrent HSL
T4	Participants 1525 1539	HSL as a wound
